High-throughput single cell analysis, sorting and dispensing using multi-laser picodroplet technology

Antibody therapeutics dominate drug development; however, lengthy workflows and rising costs in their discovery and development present significant challenges. Sphere Bio’s Cyto-Mine^® system leverages picodroplet technology, microfluidics, and optics to overcome these hurdles in Antibody Discovery and Cell Line Development, accelerating therapeutic development. Here we introduce the next-generation Cyto-Mine^® platform, Cyto-Mine^® Chroma. This advanced microfluidic platform, equipped with multi-laser, single-cell analysis capabilities, enables high-throughput, multiplex functional screening of millions of cells in a single day.